![](/img/cover-not-exists.png)
2807 Phase II explorative trial to prospectively investigate predictive molecular biomarkers for efficacy of panitumumab (P) in platinum-pretreated head and neck squamous cell cancer (HNSCC)
Siano, M., Molinari, F., Martin, V., Mach, N., Früh, M., Meehan, B., Crippa, S., Ghielmini, M., Espeli, V., Frattini, M.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31550-7
Date:
September, 2015
File:
PDF, 62 KB
english, 2015